News | January 17, 2013

GSI Group to Acquire NDS Surgical Imaging for $82.5 Million

NDS is a leading producer of high-performance visualization products sold to OEMs in the surgical endoscopy and radiology markets

January 15, 2013 — GSI Group Inc., a leading supplier of laser-based solutions, precision motion and optical technologies to global industrial, medical, electronics and scientific markets, announced that it has acquired NDS Surgical Imaging (NDS), a San Jose, Calif.-based global leader in surgical and radiology displays and related peripherals, for $82.5 million in cash, subject to customary closing adjustments.

"The acquisition of NDS Surgical Imaging provides GSI with market-leading positions in the medical and surgical arenas, based on highly engineered technologies supplied into demanding applications," said John Roush, chief executive officer of GSI. "The addition of NDS significantly expands our existing medical OEM sales channels and leverages our expertise in color measurement.  This acquisition enhances our relevancy to major medical OEM customers, and opens up additional organic growth and acquisition opportunities, particularly within the surgical arena." 

The acquisition resulted from the company's medical component market strategy, which has been in process for over a year. The combined technology platforms will expand GSI's portfolio of highly differentiated photonic technologies supplied to leading global OEM customers. In addition, the medical applications NDS serves with its products are adjacent to several of GSI's existing medical applications. There are also a number of shared customers, which is expected to strengthen the company's key OEM customer relationships.

  • NDS's primary technology consists of high-resolution flat panel displays, assembled into medical grade enclosures, with proprietary customer specific color correction software algorithms
  • NDS's products are Class I and Class II medical devices (FDA-regulated), with extremely high performance specifications, which are custom-matched to OEM optical requirements
  • The business offers a complete line of surgical visualization products, including displays, wireless imaging peripherals, and informatics and connectivity solutions
  • NDS is a recognized technology leader within the space and has been first to market with many innovations, including:
  • Surgical liquid crystal displays (LCDs)
  • LED backlights with backlight stabilization in a surgical display
  • Patent-pending color correction technology and automated LCD calibration technology
  • 510(k) approval for LCDs for mammography
  • 3 and 5 megapixel (MP) medically certified diagnostic LCDs
  • Ultra-wideband (UWB) wireless technology in the surgical suite

"NDS Surgical Imaging is a leader in the industry, with significant exposure to the minimally invasive surgical and diagnostics markets in both developed and developing countries," said Roush. "With nearly 40 percent of GSI's pro forma revenue generated from the medical market, the acquisition is a significant step for us in achieving our strategic goals." 

The total purchase price of $82.5 million is financed using approximately $25 million of cash on-hand with the remainder from the company's new credit facility. The acquisition closed as of Jan. 15, 2013. The transaction is earnings accretive and is expected to add more than $80 million in revenue and nearly $12 million of adjusted EBITDA to GSI's financial results in 2013.  

Houlihan Lokey acted as the sole financial advisor to GSI and provided a fairness opinion to GSI's Board of Directors.

For more information: www.ndssi.comwww.gsig.com

Related Content

American Society for Gastrointestinal Endoscopy and Touch Surgery Pilot Video-Based Endoscopic Simulations
News | Endoscopes | June 11, 2018
During the 2018 Digestive Disease Week (DDW) conference June 2-5 in Washington, D.C., the American Society for...
Olympus and Hitachi Healthcare Americas Introduce Arietta 850
News | Ultrasound Imaging | June 04, 2018
Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedu
Body Vision Medical Receives FDA Clearance for LungVision Tool
Technology | Lung Cancer | May 09, 2018
Body Vision Medical received clearance from the U.S. Food and Drug Administration (FDA) to market their LungVision Tool...
El Camino Hospital Performs First U.S. Robotic Lung Cancer Bronchoscopy
News | Oncology Diagnostics | April 25, 2018
The interventional pulmonology team at the Taft Center for Clinical Research at El Camino Hospital in Mountain View,...
Flat Panel Display Market Outlook

Photo courtesy of Barco

Feature | Flat Panel Displays | April 18, 2018 | Melinda Taschetta-Millane
The global flat panel display market is predicted to reach $177.3 million by 2027, according to a new report titled “...
News | Endoscopes | April 02, 2018
Results from a recent prospective trial found the Wide Area Transepithelial Sampling with 3D Tissue Analysis (WATS3D)...
Canvys Introduces New 27- and 32-inch 4K Ultra HD Displays
Technology | Flat Panel Displays | March 30, 2018
Canvys, a Division of Richardson Electronics Ltd., recently enhanced its 4K Ultra HD custom display series of high-...
Auris Health Unveils FDA-Cleared Monarch Platform for Robotic Bronchoscopy
Technology | Endoscopes | March 26, 2018
March 26, 2018 — Auris Health Inc. announced U.S.
FDA, CDC and ASM Release New Duodenoscope Surveillance and Culturing Protocols
News | Endoscopes | February 26, 2018
The U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC) and American Society for...
Sponsored Content | Videos | Flat Panel Displays | February 21, 2018
This 5 megapixel, high-brightness color monitor has the high-definition display necessary for breast imaging.